Fludarabine Ameliorates Lupus Nephritis by Inhibiting T Cell Infiltration through STAT1 in R848-induced Mice Models
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease caused by both genetic and environmental factors. Fludarabine is a selective inhibitor of signal transducer and activator of transcription 1 (STAT1). Recently, STAT1 inhibitors have been considered potential treatments for SLE, due to the relationship between its pathogenesis and STAT1 pathway-mediated cytokines such as interferons. In the current study, we evaluated the therapeutic effects of fludarabine in an SLE animal model and explored its effects on T cell responses. 12-week-old C57BL/6 mice with topically administered R848 exhibited lupus-like phenotypes. Disease activity, such as proteinuria, autoantibody levels, immunoglobulin titers, the histological score, and C3 deposition, greatly improved with fludarabine treatment. In addition, fludarabine inhibited CD4+ T cells and T helper 1 (Th1) cells in the spleen and significantly decreased the differentiation of Th1 cells in vitro. These results indicate that Th1 cells play a critical role in the pathogenesis of lupus nephritis (LN). Thus, fludarabine exerted therapeutic effects on lupus animal models by suppressing Th1 cells via STAT1 inhibition. We propose that targeting STAT1 signaling using fludarabine could be an effective therapy for treating LN.
Abstract
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease caused by both genetic and environmental factors. Fludarabine is a selective inhibitor of signal transducer and activator of transcription 1 (STAT1). Recently, STAT1 inhibitors have been considered potential treatments for SLE, due to the relationship between its pathogenesis and STAT1 pathway-mediated cytokines such as interferons. In the current study, we evaluated the therapeutic effects of fludarabine in an SLE animal model and explored its effects on T cell responses. 12-week-old C57BL/6 mice with topically administered R848 exhibited lupus-like phenotypes. Disease activity, such as proteinuria, autoantibody levels, immunoglobulin titers, the histological score, and C3 deposition, greatly improved with fludarabine treatment. In addition, fludarabine inhibited CD4+ T cells and T helper 1 (Th1) cells in the spleen and significantly decreased the differentiation of Th1 cells in vitro. These results indicate that Th1 cells play a critical role in the pathogenesis of lupus nephritis (LN). Thus, fludarabine exerted therapeutic effects on lupus animal models by suppressing Th1 cells via STAT1 inhibition. We propose that targeting STAT1 signaling using fludarabine could be an effective therapy for treating LN.
참고문헌 (24)
- Trouw LA, "The complement system as a potential therapeutic target in rheumatic disease", Nat Rev Rheumatol, 13, pp.538~547 (2017)[DOI]
- Fu SM, "Anti-dsDNA Antibodies are one of the many autoantibodies in systemic lupus erythematosus", F1000Res, 4, pp.939~ (2015)[DOI]
- Qi S, "Clinical application of protein biomarkers in lupus erythematosus and lupus nephritis", Lupus, 27, pp.1582~1590 (2018)[DOI]
- Katsuyama T, "Aberrant T cell signaling and subsets in systemic lupus erythematosus", Front Immunol, 9, pp.1088~ (2018)[DOI]
- Tang YY, "Th1-related transcription factors and cytokines in systemic lupus erythematosus", Front Immunol, 14, pp.1305590~ (2023)[DOI]
- Szabo PA, "Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease", Nat Commun, 10, pp.4706~ (2019)[DOI]
- Chodisetti SB, "Type II but not type I IFN signaling is indispensable for TLR7-promoted development of autoreactive B Cells and systemic autoimmunity", J Immunol, 204, pp.796~809 (2020)[DOI]
- Banik S, "The role of STAT1 in T helper cell differentiation during breast cancer progression", J Breast Cancer, 24, pp.253~265 (2021)[DOI]
- Kim HS, "STAT1 as a key modulator of cell death", Cell Signal, 19, pp.454~465 (2007)[DOI]
- Karonitsch T, "Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells", Arthritis Rheum, 60, pp.1463~1471 (2009)[DOI]
- Dufour A, "C-terminal truncation of IFN-γ inhibits proinflammatory macrophage responses and is deficient in autoimmune disease", Nat Commun, 9, pp.2416~ (2018)[DOI]
- Gao C, "Fludarabine inhibits infection of Zika virus, SFTS phlebovirus, and Enterovirus A71", Viruses, 13, pp.774~ (2021)[DOI]
- Illei GG, "Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis", Rheumatology(Oxford), 46, pp.952~956 (2007)[DOI]
- Li W, "An update on lupus animal models", Curr Opin Rheumatol, 29, pp.434~441 (2017)[DOI]
- Perry D, "Murine models of systemic lupus erythematosus", J Biomed Biotechnol, 2011, pp.271694~ (2011)[DOI]
- Subramanian S, "A Tlr7 translocation accelerates systemic autoimmunity in murine lupus", Proc Natl Acad Sci U S A, 103, pp.9970~9975 (2006)[DOI]
- Wirth JR, "TLR7 agonism accelerates disease and causes a fatal myeloproliferative disorder in NZM 2410 lupus mice", Front Immunol, 10, pp.3054~ (2020)[DOI]
- Karrar S, "Abnormal B cell development in systemic lupus erythematosus : what the genetics tell us", Arthritis Rheumatol, 70, pp.496~507 (2018)[DOI]
- Dolff S, "Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus", Clin Immunol, 141, pp.197~204 (2011)[DOI]
- Villarino AV, "STAT1-activating cytokines limit Th17 responses through both T-bet-dependent and -independent mechanisms", J Immunol, 185, pp.6461~6471 (2010)[DOI]
- Paquissi FC, "The Th17", IL-17 axis and kidney diseases, with focus on lupus nephritis, 2021, pp.8, 654912~
- Zhou L, "IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways", Nat Immunol, 8, pp.967~974 (2007)[DOI]
- Yang XO, "T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma", Immunity, 28, pp.29~39 (2008)[DOI]
- Butturini E, "Redox Regulation of STAT1 and STAT3 signaling", Int J Mol Sci, 21, pp.7034~ (2020)[DOI]